BSE filing, BSE: 544544. Summary written from the filing by ALFA Finder's alert engine.
Telge Projects Ltd: key numbers
- Share price
- ₹210.00
- Market cap
- ₹205.6 Cr
- Revenue (annual)
- ₹40.21 Cr
- Net profit (annual)
- ₹5.94 Cr
- P/E (TTM)
- 34.6×Sector 33.5×
- Promoter holding
- 72.82%+0.66% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Telge Projects Ltd
All →Telge Projects Investor Presentation: Key Takeaways
H1 FY27 revenue from operations ₹34.2 Cr; order book ₹14 Cr plus ₹8 Cr pipeline. 80% of revenue from USA; asset-light engineering model, D/E 0.15x. Net profit and EBITDA not disclosed.
Telge Projects Q2 FY27 Results: Net Profit ₹1.9 Cr, Up 171.4% YoY
Telge Projects Ltd reported revenue from operations of ₹17.2 Cr (+109.8% YoY) and net profit of ₹1.9 Cr (+171.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.9 Cr · +171.4% YoY
Telge Projects Board Meeting Date
Telge Projects Ltd has scheduled its Board meeting for November 13, 2026, to consider Q1/H1 FY27 financial results. The trading window remains closed until November 15, 2026.
Telge Projects Other Announcement
Telge Projects filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter group holds 100% of the shares after the reporting period.
Telge Projects Annual General Meeting
Telge Projects Ltd disclosed voting results of its EGM held 23 October 2026, with all resolutions approved. Resolution 1 (increase in authorised share capital and MoA amendment) passed with 100% votes in favour.
Telge Projects Convertible Warrants
Telge Projects' EGM approved an authorised share capital increase and warrants convertible into equity for promoter group members. The warrant resolution passed with 100% of votes cast in favour.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr